A mutation in the amyloid precursor protein (APP), which produces plaque-forming amyloid-β (Aβ) peptides in the brains of patients with Alzheimer’s disease (AD), protects some Icelanders from age-related cognitive decline.
Because the mutation hampers the ability of the β-site APP cleaving enzyme (BACE) to produce Aβ from APP, researchers tested whether other chemical inhibitors have similarly salutary effects on AD.
The cancer drug Gleevec, known to reduce Aβ by indirectly blocking a different enzyme in the amyloid pathway, reduced BACE processing of APP in cultured mouse cell lines without directly inhibiting the enzyme. Gleevec’s dampening action on BACE had no effect on the processing of unrelated BACE substrates, underscoring the drug's specific effects on APP metabolism.
Further, administration of Gleevec to mouse cells generated atypical APP fragments, previously reported in cells with the protective Icelandic mutation. Similarly, the compound DV2-103, which, unlike Gleevec, reaches therapeutic levels in rodent brains, reduced APP processing by BACE.
More importantly, within 4 hours of intraperitoneal injection of 15 mg/kg DV2-103, a transgenic mouse model of AD displayed a decrease in brain Aβ levels to around 60% of that observed in mice that did not receive the compound.
According to the authors, drugs that selectively alter BACE processing of APP hold promise for preventing or delaying the onset of AD.
http://www.pnas.org/content/early/2017/01/17/1620963114
Latest News
Abusive drugs hijack natura…
By newseditor
Posted 23 Apr
Mechanism of action of the…
By newseditor
Posted 23 Apr
Role of fat in rare neurolo…
By newseditor
Posted 23 Apr
How protein synthesis in de…
By newseditor
Posted 22 Apr
Atlas of mRNA variants in d…
By newseditor
Posted 22 Apr
Other Top Stories
A newly discovered signaling molecule helps neurons find their way…
Read more
Rescue of neonatal cardiac dysfunction in mice by administration of…
Read more
Teens are not as good at multitasking as adults
Read more
Schizophrenia-associated genetic variants affect gene regulation in…
Read more
Role of long intervening noncoding RNAs (lincRNAs) in skeletal musc…
Read more
Protocols
A programmable targeted pro…
By newseditor
Posted 23 Apr
MemPrep, a new technology f…
By newseditor
Posted 08 Apr
A tangible method to assess…
By newseditor
Posted 08 Apr
Stem cell-derived vessels-o…
By newseditor
Posted 06 Apr
Single-cell biclustering fo…
By newseditor
Posted 01 Apr
Publications
Exploiting pancreatic cance…
By newseditor
Posted 23 Apr
Structure of antiviral drug…
By newseditor
Posted 23 Apr
Type-I-interferon-responsiv…
By newseditor
Posted 23 Apr
Selenium, diabetes, and the…
By newseditor
Posted 23 Apr
Long-term neuropsychologica…
By newseditor
Posted 23 Apr
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar